Jenifer Vallejo

Jenifer Vallejo

Auto-generated profile, based on publicly available information

Jenifer Vallejo

La Jolla Institute for Immunology, La Jolla, CA 92037, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2022 in Science
Verified
Journal Article
Closed access
MOMarco C. Orecchioni
Marco C. Orecchioni
KKKouji Kobiyama
Kouji Kobiyama
HWHolger Winkels
Holger Winkels
YGYanal Ghosheh
Yanal Ghosheh
SMSara McArdle
Sara McArdle
Klaus LeyKlaus Ley
Klaus Ley
Sniffing out atherosclerosis: Olfactory receptors are best known for their presence in the nose and their role in detecting smells, but they are also present in other tissues and perform additional biological functions. For example, vascular macrophages involved in the pathogenesis of atherosclerosis express multiple subtypes of olfactory receptors. Orecchioni et al . focused on olfactory receptor 2, a receptor for the compound octanal, and identified its contribution to atherosclerosis pathogenesis and the formation of atherosclerotic plaques (see the Perspective by Rayner and Rasheed). The authors show that most of the octanal was not directly derived from the diet, but rather was generated as a by-product of lipid peroxidation, suggesting a potential pathway for intervention. —YN

3 August 2021 in Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
JVJenifer Vallejo
Jenifer Vallejo
CCClément Cochain
Clément Cochain
AZAlma Zernecke
Alma Zernecke
Klaus LeyKlaus Ley
Klaus Ley
Immune cells in atherosclerosis include T, B, natural killer (NK) and NKT cells, macrophages, monocytes, dendritic cells (DCs), neutrophils, and mast cells. Advances in single-cell RNA sequencing (sRNA-Seq) have refined our understanding of immune cell subsets. Four recent studies have used scRNA-Seq of immune cells in human atherosclerotic lesions and peripheral blood mononuclear cells (PBMCs), some including cell surface phenotypes revealed by oligonucleotide-tagged antibodies, which confirmed known and identified new immune cell subsets and identified genes significantly up-regulated in PBMCs from HIV+ subjects with atherosclerosis compared to PBMCs from matched HIV+ subjects without atherosclerosis. The ability of scRNA-Seq to identify cell types is greatly augmented by adding cell surface phenotype using antibody sequencing. In this review, we summarize the latest data obtained by scRNA-Seq on plaques and human PBMCs in human subjects with atherosclerosis.

12 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JVJ. Vallejo
J. Vallejo
PDPontus Dunér
Pontus Dunér
FTF. To
F. To
DED. Engelbertsen
D. Engelbertsen
IGI. Gonçalves
I. Gonçalves
EBE. Bengtsson
E. Bengtsson
Oxidation of low-density lipoprotein (LDL) in the arterial extracellular matrix results in malondialdehyde (MDA)-modifications of surrounding matrix proteins. We have recently demonstrated an association between high levels of autoantibodies against MDA-modified collagen type IV and risk for development of myocardial infarction. Collagen type IV is an important component of the endothelial basement membrane and influences smooth muscle cell function. We hypothesized that immune responses against collagen type IV could contribute to vascular injury affecting the development of atherosclerosis. To investigate this possibility, we induced an antibody-response against collagen type IV in apolipoprotein E (Apo E)-deficient mice. Female ApoE−/− mice on C57BL/6 background were immunized with α1α2 type IV collagen chain peptides linked to the immune-enhancer PADRE, PADRE alone or PBS at 12 weeks of age with three subsequent booster injections before the mice were killed at 23 weeks of age. Immunization of PADRE alone induced autoantibodies against PADRE, increased IL-4 secretion from splenocytes and reduced SMC content in the subvalvular plaques. Immunization with peptides of α1α2 type IV collagen chains induced a strong IgG1antibody response against collagen type IV peptides without affecting the distribution of T cell populations, plasma cytokine or lipid levels. There were no differences in atherosclerotic plaque development between collagen α1α2(IV)-PADRE immunized mice and control mice. Our findings demonstrate that the presence of antibodies against the basement membrane component collagen type IV does not affect atherosclerosis development in ApoE−/− mice. This suggests that the association between autoantibodies against collagen type IV and risk for myocardial infarction found in humans does not reflect a pathogenic role of these autoantibodies.

25 September 2017 in Journal of Internal Medicine
Verified
Journal Article
Closed access
PDF file
JVJ. Vallejo
J. Vallejo
PDP. Dunér
P. Dunér
GFG. N. Fredrikson
G. N. Fredrikson
JNJan Nilsson
Jan Nilsson
EBE. Bengtsson
E. Bengtsson